Prapela? SVS incubator pad: a cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity. - prapela proposes to complete the development of and…

Active Cooperative Agreement Awarded Last action

Award ID
U44DA059380
Recipient
Awarding agency
Obligated
$8,905,849

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 89% complete
Originally
Place of performance
Portland, ME 04101, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Prapela? SVS incubator pad: a cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity. - prapela proposes to complete the development of and then establish the safety, efficacy, and clinical risk/benefit of a novel hospital incubator pad that will provide a complementary treatment and the first improvement in the clinical management of apnea of prematurity (AOP) in over 20 years. Defined as cessation of breathing for 20 seconds or longer or a shorter pause accompanied by hypoxemia, AOP is a major morbidity among preterm infants and a significant healthcare burden. AOP affects 70% of all early preterm births (

Transactions

Action Obligated Date
Amendment $0
Amendment $1,475,909
Amendment $1,475,909
Amendment $0
Amendment $0
Amendment $1,484,463
Amendment $1,484,463
Amendment $1,484,463
Amendment $500,214
Amendment $500,214
Original award $500,214
Show all 11

Quick answers

Who received award U44DA059380?

U44DA059380 was awarded to Prapela Inc. by National Institute on Drug Abuse (National Institutes of Health) on April 1, 2023.

How much is award U44DA059380 worth?

$8,905,849 has been obligated on U44DA059380.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login